Neumora Therapeutics Ownership | Who Owns Neumora Therapeutics?


OverviewForecastFinancialsChartTranscripts

Neumora Therapeutics Ownership Summary


Neumora Therapeutics is owned by 13.72% institutional investors, 23.93% insiders, and 62.35% retail investors. Siren is the largest institutional shareholder, holding 5.20% of NMRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.88% of its assets in Neumora Therapeutics shares.

NMRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNeumora Therapeutics13.72%23.93%62.35%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Siren8.50M5.20%$16.57M
Softbank group6.09M3.73%$11.88M
Vanguard group4.54M2.80%$8.13M
Mic capital management uk llp4.46M2.73%$8.70M
Fmr3.50M2.14%$6.82M
Wellcome trust ltd (the) as trustee of the wellcome trust3.31M2.03%$6.45M
Millennium management2.75M1.69%$5.37M
Iconiq capital2.56M1.57%$4.99M
Lunate capital2.12M1.30%$4.14M
Blackrock funding, inc. /de2.05M1.26%$4.01M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lunate capital2.12M3.44%$4.14M
Mic capital management uk llp4.46M2.47%$8.70M
Johnson & johnson1.85M0.55%$3.61M
Siren8.50M0.46%$16.57M
Ikarian capital1.28M0.20%$2.49M
Addis & hill163.39K0.19%$318.60K
Iconiq capital2.56M0.11%$4.99M
Softbank group6.09M0.10%$11.88M
Velan capital investment management lp80.00K0.10%$156.00K
Wellcome trust ltd (the) as trustee of the wellcome trust3.31M0.08%$6.45M

Top Buyers

HolderShares% AssetsChange
Siren8.50M0.46%2.21M
Tudor investment corp et al771.42K0.00%771.42K
Two sigma investments, lp2.04M0.00%729.00K
Marshall wace, llp1.20M0.00%611.55K
Vanguard fiduciary trust535.03K0.00%535.03K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---5.10M
Capital investors---3.70M
Ecor1 capital---2.07M
Baker bros. advisors lp---1.03M
Adage capital partners gp---1.00M

New Positions

HolderShares% AssetsChangeValue
Tudor investment corp et al771.42K0.00%771.42K$1.50M
Vanguard fiduciary trust535.03K0.00%535.03K$1.04M
Caption management412.20K0.00%412.20K$803.79K
Qube research197.36K0.00%197.36K$384.86K
Velan capital investment management lp80.00K0.10%80.00K$156.00K

Sold Out

HolderChange
Gamma investing-16.00
Ifp advisors-32.00
Ronald blue trust-38.00
Lindbrook capital-48.00
Corecap advisors-57.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202649-53.77%22,411,846-64.48%130.90%23-58.18%10-56.52%
Dec 31, 202565-35.00%32,985,290-34.97%202.07%29-12.12%14-65.00%
Sep 30, 202598-4.85%49,889,004-11.08%302.56%32-38.46%3930.00%
Jun 30, 2025100-13.79%56,072,937-7.73%342.45%50-20.63%30-6.25%
Mar 31, 2025116-27.95%65,233,669-16.60%401.68%62-31.11%32-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.44M1.88%639.40K
Vanguard Morn Total Stk Mkt Idx Investor3.44M1.88%639.40K
iShares Russell 2000 ETF2.45M1.34%-43.49K
Vanguard Institutional Extnd Mkt Idx Tr1.13M0.62%106.15K
iShares Russell 2000 Growth ETF850.85K0.47%-7.80K
Russell 2000 Index Non-Lendable Fund664.04K0.36%664.04K
Russell 2000 Equity Index Fund B664.04K0.36%664.04K
Vanguard Russell 2000 ETF593.24K0.32%593.24K
iShares Biotechnology ETF560.07K0.31%-1.71K
Fidelity Extended Market Index509.29K0.28%43.91K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 17, 2026Aurora Daljit Singh See RemarksSell$21.92K
Feb 17, 2026Pinto Joshua PresidentSell$21.09K
Feb 17, 2026BERNS PAUL L See RemarksSell$34.46K
Feb 17, 2026Milligan Michael Lee See RemarksSell$5.12K
Nov 11, 2025Aurora Daljit Singh See RemarksSell$307.03K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1-4
2025 Q431
2025 Q2--
2025 Q1-5

NMRA Ownership FAQ


Who Owns Neumora Therapeutics?

Neumora Therapeutics shareholders are primarily institutional investors at 13.72%, followed by 23.93% insiders and 62.35% retail investors. The average institutional ownership in Neumora Therapeutics's industry, Biotech Stocks , is 49.09%, which Neumora Therapeutics falls below.

Who owns the most shares of Neumora Therapeutics?

Neumora Therapeutics’s largest shareholders are Siren (8.5M shares, 5.20%), Softbank group (6.09M shares, 3.73%), and Vanguard group (4.54M shares, 2.80%). Together, they hold 11.73% of Neumora Therapeutics’s total shares outstanding.

Does Blackrock own Neumora Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Neumora Therapeutics.

Who is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested?

Lunate capital is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.44% of its assets in 2.12M Neumora Therapeutics shares, valued at 4.14M$.

Who is the top mutual fund holder of Neumora Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Neumora Therapeutics shares, with 1.88% of its total shares outstanding invested in 3.44M Neumora Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools